BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20208141)

  • 1. Gene promoter methylation patterns throughout the process of cervical carcinogenesis.
    Yang N; Nijhuis ER; Volders HH; Eijsink JJ; Lendvai A; Zhang B; Hollema H; Schuuring E; Wisman GB; van der Zee AG
    Cell Oncol; 2010; 32(1-2):131-43. PubMed ID: 20208141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.
    Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
    Gynecol Oncol; 2010 Jan; 116(1):99-104. PubMed ID: 19836067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings.
    Yang N; Eijsink JJ; Lendvai A; Volders HH; Klip H; Buikema HJ; van Hemel BM; Schuuring E; van der Zee AG; Wisman GB
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3000-7. PubMed ID: 19843677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CADM1, MAL, and miR124 Promoter Methylation as Biomarkers of Transforming Cervical Intrapithelial Lesions.
    Del Pino M; Sierra A; Marimon L; Martí Delgado C; Rodriguez-Trujillo A; Barnadas E; Saco A; Torné A; Ordi J
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCNA1 promoter methylation: a potential marker for grading Papanicolaou smear cervical squamous intraepithelial lesions.
    Chujan S; Kitkumthorn N; Siriangkul S; Mutirangura A
    Asian Pac J Cancer Prev; 2014; 15(18):7971-5. PubMed ID: 25292097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation profiling of cervical squamous intraepithelial lesions using liquid-based cytology specimens: an approach that utilizes receiver-operating characteristic analysis.
    Gustafson KS; Furth EE; Heitjan DF; Fansler ZB; Clark DP
    Cancer; 2004 Aug; 102(4):259-68. PubMed ID: 15368319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy.
    Lim EH; Ng SL; Li JL; Chang AR; Ng J; Ilancheran A; Low J; Quek SC; Tay EH
    Gynecol Oncol; 2010 Nov; 119(2):225-31. PubMed ID: 20708786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests.
    Kahn SL; Ronnett BM; Gravitt PE; Gustafson KS
    Cancer; 2008 Feb; 114(1):57-64. PubMed ID: 18181097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation in the promoters of HS3ST2 and CCNA1 genes is associated with cervical cancer in Uygur women in Xinjiang.
    Zuo Q; Zheng W; Zhang J; Pan Z; Liu Y; Long H; Fan P; Guo C; Li F; Shao R
    Int J Biol Markers; 2014 Dec; 29(4):e354-62. PubMed ID: 25198553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.
    Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Kweon SS; Fackler MJ; Sukumar S
    Virchows Arch; 2010 Jul; 457(1):35-42. PubMed ID: 20496080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16.
    Ki EY; Lee KH; Hur SY; Rhee JE; Kee MK; Kang C; Park JS
    Int J Gynecol Cancer; 2016 Jan; 26(1):176-83. PubMed ID: 26552048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility study.
    Salta S; Maia-Moço L; Estevão-Pereira H; Sequeira JP; Vieira R; Bartosch C; Petronilho S; Monteiro P; Sousa A; Baldaque I; Rodrigues J; Sousa H; Tavares F; Henrique R; Jerónimo C
    Int J Cancer; 2021 Dec; 149(11):1916-1925. PubMed ID: 34460099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Death-associated protein kinase promoter (DAPK) hypermethylation in uterine cervical cancer and intraepithelial neoplasia in Uyghur nationality women].
    Niyazi M; Liu XW; Zhu KC
    Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):31-4. PubMed ID: 22490852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia.
    Lendvai Á; Johannes F; Grimm C; Eijsink JJ; Wardenaar R; Volders HH; Klip HG; Hollema H; Jansen RC; Schuuring E; Wisman GB; van der Zee AG
    Epigenetics; 2012 Nov; 7(11):1268-78. PubMed ID: 23018867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Gene Promoter Methylation and Cervical Cancer Development: Global Distribution and A Meta-analysis.
    El Aliani A; El-Abid H; El Mallali Y; Attaleb M; Ennaji MM; El Mzibri M
    Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):450-459. PubMed ID: 33441308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter methylation of SFRPs gene family in cervical cancer.
    Chung MT; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Chu TY; Lai HC; Lin YW
    Gynecol Oncol; 2009 Feb; 112(2):301-6. PubMed ID: 19038436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel DNA methylation markers in cervical cancer.
    Lai HC; Lin YW; Huang TH; Yan P; Huang RL; Wang HC; Liu J; Chan MW; Chu TY; Sun CA; Chang CC; Yu MH
    Int J Cancer; 2008 Jul; 123(1):161-7. PubMed ID: 18398837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene amplification and immunohistochemical expression of ERBB2 and EGFR in cervical carcinogenesis. Correlation with cell-cycle markers and HPV presence.
    Conesa-Zamora P; Torres-Moreno D; Isaac MA; Pérez-Guillermo M
    Exp Mol Pathol; 2013 Oct; 95(2):151-5. PubMed ID: 23827764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.
    Boers A; Wang R; van Leeuwen RW; Klip HG; de Bock GH; Hollema H; van Criekinge W; de Meyer T; Denil S; van der Zee AGJ; Schuuring E; Wisman GBA
    Clin Epigenetics; 2016; 8():29. PubMed ID: 26962367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias.
    Lai HC; Lin YW; Chang CC; Wang HC; Chu TW; Yu MH; Chu TY
    Gynecol Oncol; 2007 Mar; 104(3):629-35. PubMed ID: 17097722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.